| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institute of Maternal-Fetal Biology, Division of Cancer and Developmental Biology, Departments of Pathology and Laboratory Medicine (J.J.B., M.J.S.), Molecular and Integrative Physiology (J.K.H.-C., M.J.S.), and Obstetrics and Gynecology (M.J.S.), University of Kansas Medical Center, Kansas City, Kansas 66160
Address all correspondence and requests for reprints to: Dr. Michael J. Soares, Institute of Maternal-Fetal Biology, Division of Cancer and Developmental Biology, Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160. E-mail: msoares{at}kumc.edu.
| Abstract |
|---|
|
|
|---|
. The two proteins exhibit structural similarities but possess distinct cell- and temporal-specific expression profiles. In vivo hypoxia stimulates placental PLP-F
and PLP-E mRNA expression in the rat and mouse, respectively. Rcho-1 trophoblast cells can differentiate into trophoblast giant cells, express PLP-F
, and exhibit enhanced PLP-F
mRNA levels when cultured under low oxygen tension (2%). Exposure to hypobaric hypoxia during latter part of pregnancy did not significantly impact the expression of PLP-Fß mRNA. Finally, exposure to hypobaric hypoxia during midpregnancy led to increased maternal red blood cells, hemoglobin concentrations, hematocrit, and increased concentrations of maternal splenic mRNAs for key proteins involved in hemoglobin synthesis, erythroid Krüppel-like factor, erythroid 5-aminolevulinate synthase-2, and ß-major globin. In summary, adaptive responses to maternal hypoxia include activation of placental PLP-F
/E gene expression, which may then participate in maternal hematological adjustments required for maintaining maternal and fetal oxygen delivery. | Introduction |
|---|
|
|
|---|
Maternal hypoxia is an effective tool to investigate the involvement of the PRL family in adaptations to physiological stressors (7). At least one member of the PRL family, PLP-A, has been shown to contribute to pregnancy-dependent adaptations to maternal hypoxia (8). Other members of the PRL family are involved in regulating key biological processes that are typically associated with adaptations to hypoxia. The latter PRL family members include the PLP-F subfamily, which has been shown to regulate hematopoiesis, including red blood cell development (9, 10, 11, 12, 13, 14, 15). Three PLP-F subfamily members have been reported; two from the mouse, PLP-E and PLP-F (16, 17), and one from the rat, PLP-F (18). PLP-E is expressed in trophoblast giant cells (16) and is an effective stimulator of erythropoiesis (10, 15) and could be part of a pregnancy-dependent adaptive mechanism ensuring adequate red blood cell oxygen delivery. Mouse PLP-F is expressed predominantly by spongiotrophoblast cells (16) and has been shown to similarly stimulate hematopoiesis (13). Although rat PLP-F is slightly more similar in structure to mouse PLP-F, its expression pattern more closely resembles mouse PLP-E (18).
In this report, we identify and characterize a new member of the rat PLP-F subfamily and demonstrate that the expression of some PLP-F subfamily members is regulated by maternal hypoxia.
| Materials and Methods |
|---|
|
|
|---|
In vivo hypoxia
On the designated day of pregnancy, female rats or mice were placed in hypobaric chambers. Two conditions were used. Rats were exposed to conditions, in which air is circulated at a barometric pressure of approximately 380 Torr, which results in an inspired PO2 of approximately 70 Torr, equivalent to breathing 10% O2 at sea level, whereas mice were exposed to conditions, in which air is circulated at a barometric pressure of approximately 420 Torr, which results in an inspired PO2 of approximately 78 Torr, equivalent to breathing 11% O2 at sea level (7). The chambers were opened daily to replenish food and water (1520 min). Pair-fed and ad libitum-fed control pregnant rats were exposed to ambient conditions (barometric pressure of
760 Torr and inspired PO2 of
149 Torr).
Rcho-1 trophoblast cell culture model
The Rcho-1 trophoblast cell line represents an in vitro model for studying rat trophoblast cells in undifferentiated and differentiated states (20, 21). Rcho-1 trophoblast cells can be maintained in a proliferative state by maintaining the cells or induced to differentiate, primarily along the trophoblast giant cell lineage (20, 21). Rcho-1 trophoblast cells were maintained in a proliferative state by culturing under subconfluent conditions with RPMI 1640 culture medium supplemented with 20% fetal bovine serum (FBS), 50 µM 2-mercaptoethanol, 1 mM sodium pyruvate, 100 U/ml of penicillin, and 100 µg/ml of streptomycin (21). Differentiation was induced by growing cells to near confluence in FBS-supplemented culture medium and then replacing the culture medium with NCTC 135 culture medium supplemented with 1% horse serum, 50 µM 2-mercaptoethanol, 1 mM sodium pyruvate, 100 U/ml penicillin, and 100 µg/ml streptomycin (21). Trophoblast giant cell differentiation is facilitated by high cell density and the removal of factors capable of stimulating proliferation (removal of FBS) (21). During differentiation, cells were maintained under ambient (21% O2) or low oxygen (2% O2) levels in a BioSpherix OxyCycler incubator/glove box (BioSpherix Ltd., Redfield, NY). These in vitro conditions of low oxygen tension do not necessarily equate with the in vivo maternal hypoxia described above.
Identification and characterization of a new member of the PLP-F subfamily
A new member of the PLP-F subfamily was identified by BLAST analysis (22) using the rat PLP-F nucleotide sequence (18) against the public rat genome assembly (Rat Genome Sequencing Project Consortium, 2004; http://rat.ensembl.org, http://genome.brc.mcw.edu/cgi-bin/hgGateway?org=Rat&db=rn3&hgsid=375405, and http://www.ncbi.nlm.nih.gov/genome/seq/MmBlast.html) and found on a BAC clone localized to chromosome 17 (CH230190E4; Childrens Hospital-BACPAC Resources, Oakland, CA; Baylor Rat BACtig Assembly: http://www.hgsc.bcm.tmc.edu/projects/rat/). The genomic sequence corresponding to the newly identified PLP-F subfamily member was then used to search the expressed sequence tag (EST) database (National Center for Biotechnology Information, Bethesda, MD) (22). Several ESTs with nucleotide sequences matching the genomic sequence were identified and obtained from Invitrogen (Carlsbad, CA). cDNAs were sequenced by the Northwestern Sequencing Facility of Northwestern University (Chicago, IL). The original PLP-F was renamed PLP-F
and the newly identified PLP-F family member was termed PLP-Fß. Multiple amino acid sequence alignments were generated with CLUSTAL X (23). Locations of signal peptides were determined with the SignalP software program (version 2.0.b2) (24) and based on homology with other members of the PRL family.
Analysis of mRNA expression
PRL family miniarray assay.
The PRL family miniarray is a hybridization-based tool for monitoring expression of each PRL family member (25). It has been used to monitor phenotypes of anterior pituitary, uterine, and placental tissues. The PRL family miniarray was performed as previously described (25). Total RNA was extracted using TRIzol reagent [Invitrogen, (26)]. [32P] dCTP-labeled cDNA probes were produced by reverse transcription using 5 µg total RNA. Hybridization was conducted overnight with labeled probes at 42 C. Membranes were washed, wrapped in plastic wrap, and exposed to Bio-Max film (Kodak, Rochester, NY) for 14 h and later exposed for 35 h on PhosphorImager cassettes (Amersham Pharmacia Biotech, Piscataway, NJ).
Northern blot analysis.
Northern blots were performed as previously described (27, 28). Total RNA was extracted using TRIzol, separated on 1% formaldehyde-agarose gels, and transferred to nylon membranes. Blots were probed with [32P] dCTP-labeled cDNAs for rat PLP-F
(18), the newly identified rat PLP-Fß, mouse PLP-E (17), erythroid Krüppel-like factor (EKLF; GenBank accession no. AA926284), ß-major globin (GenBank accession no. X15009), or erythroid 5-aminolevulinate synthase-2 (ALAS-2; GenBank accession no. NM_013197). A 28S rRNA cDNA probe was used to assess RNA integrity and as a loading control.
RT-PCR.
PLP-F
and PLP-Fß transcripts were assessed by RT-PCR. Total RNA was extracted from Rcho-1 trophoblast cells using TRIzol. Five micrograms of total RNA and 0.5 µg of oligo dT were used for reverse transcription reactions with Superscript II RT (Invitrogen). PCR was performed using Platinum Taq DNA High Fidelity polymerase (Invitrogen) with PLP-F
(forward: 5'-CTA CTA TTA CAC CGA GGC CT-3'; reverse: 5'-AGA ATC TTC ACT ATT GAT GGA TAA) and PLP-F ß (forward: 5'-CTG TTA AAT AAT GCC ACC AGA GT-3'; reverse: 5'-TCC AAG AGC TCC AAA TAT AAT TCC-3') specific primers. PCR was conducted for 30 cycles under the following conditions: preheat 94 C, denature 94 C for 1 min, anneal 60 C for 1 min, and extension 72 C for 1 min. PCR products were separated on 1% agarose gels and stained with ethidium bromide.
In situ hybridization.
In situ hybridization was performed as previously described (29, 30). Ten-micrometer cryosections of tissues were prepared and stored at 80 C until used. Plasmids containing cDNAs for rat PLP-F
(18) and PLP-Fß were used as templates to synthesize sense and antisense digoxigenin-labeled riboprobes according to the manufacturers instructions (Roche Molecular Biochemicals, Indianapolis, IN). Tissue sections were air dried and fixed in ice cold 4% paraformaldehyde in PBS. Prehybridizations, hybridizations, and detection of alkaline phosphatase-conjugated antidigoxigenin were performed as previously reported (29, 30).
Red blood cell analysis
Blood samples (13 ml) were collected by cardiac puncture of anesthetized rats. Blood was collected into Vacutainer tubes and stored at 4 C until analyzed. Hematological measurements were performed using an Act10 hematological analysis system (Beckman Coulter, Miami, FL) at the Hematology Core Laboratory of the University of Kansas Medical Center (Kansas City, KS). Analyses focused on red blood cell numbers, hemoglobin concentrations, and hematocrit.
Statistical analysis
Data generated were analyzed with ANOVA. The source of variation from significant F ratios will be determined with Newman-Keuls multiple comparison test (31).
| Results |
|---|
|
|
|---|
and the newly identified gene, PLP-Fß. The PLP-Fß cDNA nucleotide sequence was determined (GenBank accession no. AY741310). PLP-F
and PLP-Fß cDNAs share 81% nucleotide identity and their predicted amino acid sequences share 66% identity (Fig. 1A
and PLP-Fß consist of 250 amino acid proteins possessing a predicted 29 amino acid signal peptide and five homologously positioned cysteine residues, located at amino acids 100, 210, 215, 232, and 241. PLP-F
has an additional cysteine located at amino acid 99. The predicted amino acid sequence of PLP-F
includes three putative N-linked glycosylation sites (amino acids 35, 102, and 134), whereas PLP-Fß possesses four putative N-linked glycosylation sites (amino acids 50, 102, 134, and 244). Rat PLP-F
and PLP-Fß are closely related to mouse PLP-E and PLP-F; however, specific orthologous relationships cannot be defined.
|
was most abundant during midgestation, whereas PLP-Fß was dominant during the later stages of pregnancy.
Rcho-1 cells represent a rat trophoblast cell line capable of differentiating into trophoblast giant cells (21). RT-PCR analysis was used to determine the expression patterns of the two PLP-Fs in differentiating Rcho-1 trophoblast cells (Fig. 1C
). Differentiating Rcho-1 trophoblast cells (trophoblast giant cells) primarily expressed PLP-F
transcripts. Dissected midgestation trophoblast tissues (chorioallantoic placenta) and late gestation junctional zone served as positive controls for the PLP-Fs.
The PLP-F mRNAs were localized to gestation d 11.5 and gestation d 18.5 trophoblast tissues by in situ hybridization (Fig. 2
). PLP-F
exhibited predominantly a trophoblast giant cell distribution, and PLP-Fß showed primarily a spongiotrophoblast cell expression pattern. Consistent with the Northern blot analysis, PLP-F
expression was more prominent at d 11.5 of gestation and PLP-Fß expression was predominant at gestation d 18.5.
|
and PLP-Fß). The two genes are expressed predominantly by two different cell types (trophoblast giant cells and spongiotrophoblast cells) during different phases of pregnancy (midgestation and late gestation).
In vivo maternal hypoxia impacts PLP-F subfamily gene expression
Members of the PRL family have been shown to participate in adaptations to physiological stressors, including maternal hypoxia (8, 32, 33). Additionally, at least one member of the PLP-F subfamily specifically activates erythropoiesis (10, 15). Consequently we investigated the effects of maternal hypoxia on PRL family gene expression using the PRL family miniarray assay (25). Pregnant female rats were exposed to the equivalent of 10% oxygen from d 6.5 to 12.5 of gestation (Fig. 3A
). PRL gene family expression was assessed in chorioallantoic and choriovitelline placentas on gestation d 12.5. PLP-F
was the only PRL family member significantly stimulated by maternal hypoxia (Fig. 3B
). Choriovitelline placental PLP-F
mRNA responses were more robust and consistent than chorioallantoic placental PLP-F
responses (data not shown). The effects of maternal hypoxia in stimulating choriovitelline placental PLP-F
mRNA were verified by Northern blot analysis (Fig. 3C
).
|
share commonalities in their temporal and spatial expression patterns. Pregnant female mice were exposed to the equivalent of 11% oxygen from d 5.5 to 11.5 of gestation (Fig. 3D
Finally, we examined the affect of maternal hypoxia on the regulation of PLP-F
and PLP-Fß gene expression during the last week of gestation. Pregnant female rats were exposed to the equivalent of 10% oxygen from d 13.5 to 18.5 of gestation (Fig. 4A
). Northern blot analyses of gestation d 18.5 junctional zone tissues indicated that PLP-F
and PLP-Fß were not responsive to hypoxia (Fig. 4B
).
|
and mouse PLP-E expression respond positively to exposure to in vivo maternal hypoxia.
Impact of in vitro oxygen tension on trophoblast cell PLP-F
gene expression
Rcho-1 trophoblast cells represent an excellent in vitro model for investigating aspects of trophoblast giant cell differentiation and function (21). In the following experiments, Rcho-1 trophoblast cells were induced to differentiate while exposed to ambient or 2% oxygen for 10 d (Fig. 5A
). Northern blot analyses revealed that PLP-F
mRNA levels were significantly elevated in the 2% oxygen-exposed cell cultures (Fig. 5B
). Thus, both in vivo and in vitro models indicate that trophoblast cell PLP-F
expression is sensitive to oxygen tension.
|
|
| Discussion |
|---|
|
|
|---|
24 genes in each species) and can be classified into a number of subfamilies (3, 5). These subfamilies are based strictly on structural relatedness. They exhibit elements of conservation between the mouse and rat and also species specificity. The PLP-F subfamily is of considerable interest because of recent advances in understanding its biological roles during pregnancy (9, 10, 11, 12, 13, 14, 15). This subfamily consists of two members in the mouse (PLP-E and PLP-F) and two members in the rat (PLP-F
and PLP-Fß).
In this report, we investigate the rat PLP-F subfamily. PLP-F
and PLP-Fß exhibit significant sequence similarities and structurally are both more closely related to mouse PLP-F than to mouse PLP-E. However, based on expression profiles, PLP-F
shares similarities with mouse PLP-E, whereas PLP-Fß parallels mouse PLP-F. Furthermore, we demonstrated that exposure of pregnant rats to hypobaric hypoxia is an effective technique for investigating pregnancy-dependent adaptations. Maternal hypoxia activates placental signals, including members of the PLP-F subfamily, and maternal homeostatic responses ensuring oxygen availability and delivery to the fetus.
PLP-F subfamily genes are expressed by different trophoblast cell lineages and are differentially activated by hypoxia. Rat PLP-F
and PLP-Fß genes each possess a six-exon structure and are situated next to each other within the PRL family locus on chromosome 17 (5). Their close proximity does not correlate with their cell- and temporal-specific expression patterns. PLP-F
is expressed predominantly in trophoblast giant cells during midgestation, whereas PLP-Fß is expressed primarily by spongiotrophoblast cells during the latter part of gestation (Ref. 18 and present study). Not surprisingly, the derivation of the trophoblast giant cell and spongiotrophoblast cell lineages involve distinct regulatory pathways (34) and are differentially affected by hypoxia (35, 36, 37, 38). Midgestation rat PLP-F
and mouse PLP-E expression are stimulated by exposure to maternal hypoxia. Although the increase of PLP-F
and PLP-E expression by hypoxia is dependent on the activation of midgestation trophoblast giant cells, other trophoblast giant cell-specific genes are not similarly up-regulated by maternal hypoxia. For example, PL-I, PL-II, and PLP-M transcript levels do not change significantly in placental tissues from pregnant females exposed to hypoxia (present study). As gestation progresses, the regulation of PLP-F subfamily gene expression becomes constitutive and nonresponsive to oxygen tension. Gestational-dependent regulation of PLP-F subfamily gene expression is likely connected to the physiological demands of pregnancy and the biological activities of the PLP-F subfamily.
The PLP-F subfamily of cytokines/hormones has been linked to the regulation of hematopoiesis. PLP-E and PLP-F stimulate blood cell formation, including megakaryocyte and erythrocyte development (9, 10, 11, 12, 13, 14, 15). Hypoxia is known to differentially affect megakaryocytopoiesis and erythropoiesis. Megakaryocyte formation is inhibited by hypoxia, whereas erythrocyte development is stimulated (39, 40). Erythrocytes are key regulators of oxygen homeostasis. They synthesize hemoglobin, bind oxygen, and are fundamental for oxygen delivery to tissues (41, 42). Pregnancy represents a significant challenge to oxygen homeostasis and fetal oxygen delivery. Red blood cell numbers increase during pregnancy concomitant with expansions in blood volume and the growth demands of the fetus (43). During early postimplantation to midgestation, trophoblast giant cells are effective sensors of oxygen status. If oxygen tension is below a physiological set point, then trophoblast giant cells are activated to produce PLP-F subfamily members, especially PLP-F
and PLP-E. This midgestation regulatory loop can be further activated by exposure of pregnant rats to hypobaric hypoxia. During late pregnancy, maternal and fetal demands for oxygen are increased and PLP-F subfamily members (PLP-Fß and mouse PLP-F) are constitutively produced by spongiotrophoblast cells. Collectively, these hormones enter into maternal circulation (9) and are targeted to maternal sites of hematopoiesis (bone marrow, spleen) in which they can mimic the actions of erythropoietin and stimulate red blood cell formation (10, 15). At least one member of the PLP-F subfamily can also be activated during pathological conditions (12). The cellular mechanism of action of PLP-F subfamily cytokines/hormones is not well understood but may involve gp130 and Janus kinase/signal transducer and activator of transcription signaling pathways (9, 10).
During pregnancy, hematopoiesis is also initiated in extraembryonic and embryonic tissues. The midgestation placenta is a site of hematopoietic stem cell development (44, 45, 46), and the visceral yolk sac is an active site of erythropoiesis (41, 42). The peak in placental hematopoietic stem cell production and visceral yolk sac erythropoiesis correspond to the expression profile of PLP-F subfamily members; however, whether they have access to these extraembryonic targets and are capable of modulating their functions remains to be determined.
In summary, the placenta orchestrates adaptive responses to hypoxia, at least in part, via the elaboration of hormones and cytokines. PLP-F
and PLP-E, in the rat and mouse, respectively, represent hormones/cytokines that are responsive to maternal hypoxia and possess biological actions contributing to pregnancy-dependent regulation of oxygen homeostasis.
| Acknowledgments |
|---|
| Footnotes |
|---|
This work was supported by the National Institutes of Health (HD20676, HD39878, HD48861) and the Hall Family Foundation.
Disclosure Statement: The authors have nothing to disclose
First Published Online November 9, 2006
Abbreviations: ALAS-2, 5-Aminolevulinate synthase-2; EKLF, erythroid Krüppel-like factor; EST, expressed sequence tag; FBS, fetal bovine serum; PL, placental lactogen; PLP, PRL-like protein; PRL, prolactin.
Received August 18, 2006.
Accepted for publication November 1, 2006.
| References |
|---|
|
|
|---|
and 2
regulate trophoblast differentiation. Mol Cell Biol 25:1047910491
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |